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Cytokines play a critical role in shaping the host immune response to Leishmania infection and directing the development of
protective and non-protective immunities during infection. Cytokines exert their biological activities through the activation and
translocation of transcription factors into the nucleus whether they drive the expression of speciﬁc cytokine-responsive genes.
Signal transducer and activator of transcription (STATs) are transcription factors which play a critical role in mediating signaling
downstream of cytokine receptors and are important for shaping the host immune response during Leishmania infection. Here we
discuss the signature cytokines and their associated STATs involved in the host immune response during cutaneous and visceral
leishmaniasis.
1.Introduction
Leishmaniasis is a zoonotic disease resulting from infection
with protozoan parasites of the species Leishmania,o fw h i c h
approximately 30 diﬀerent species have been described [1].
The clinical manifestations of disease diﬀer depending on
causative species and occur in three major forms: cutaneous,
mucosal, and visceral leishmaniasis [1–3].
Leishmania infection is transmitted to susceptible mam-
malian hosts by sand ﬂies of the genus Phlebotomous and
Lutzomyia in the Old and New World, respectively [3].
Leishmania parasites exist as an extracellular promastigote
within the gut of the sand ﬂy, transforming into an intracel-
lular amastigote within macrophages of mammalian hosts.
As obligate intracellular pathogens in mammals, parasite
survival and replication requires that parasites are rapidly
internalized by host cells. While macrophages are considered
to be critical eﬀector cells in eliminating parasites and
resolving disease, these cells play an important role during
infection as the deﬁnitive host cell in which Leishmania
species survive and replicate [4].
The genetic background of the host plays an important
role in determining host resistance or susceptibility and dis-
ease outcome [5]. T lymphocytes play critical role in shaping
the host immune response by secreting cytokines, which
may act both synergistically and antagonistically through
complex signaling pathways to direct both protective and
non-protective immunities against intracellular parasites.
Early studies using mouse models of experimental CL have
revealedacleardichotomybetweenTh1-associatedcytokines
mediating protection and Th2-associated cytokines medi-
ating susceptibility [5, 6]. On the other hand during VL,
Th2 response and cytokines such as IL-4 and IL-13 seem
to be necessary for immunity and eﬃcient response to
antileishmanial chemotherapy [7, 8].
The ability of the host to control infection and resolve
disease requires the generation of cell-mediated immune
responses capable of activating host macrophages to elimi-
nate intracellular parasites. In both human and experimental
models of CL, control of infection is mediated by T
lymphocytes and is critically dependent upon the early
induction of an IL-12-driven Th1-type immune response
and the production of IFN-γ by CD4+ T cells [5, 9]. IFN-
γ plays a critical role in the activation of macrophages to kill
intracellular parasites by inducing production of nitric oxide
which is critical for elimination of parasites [6].2 Journal of Biomedicine and Biotechnology
Previous studies have shown that susceptibility to infec-
tion and disease progression in CL is driven largely by
the induction of a non-protective, IL-4-driven Th2-type
immune response and the production of Th2-associated
cytokines IL-4, IL-10, IL-13, and TGF-β [9–12]. In experi-
mental models of murine CL, IL-4 was shown to play a criti-
calroleinmediatingsusceptibilitytoLeishmaniainfectionby
down-regulating the expression of protective Th1-associated
cytokines IL-12 and IFN-γ and by inhibiting NO production
and parasite killing by macrophages [6]. Nonetheless, some
studies using IL-4-deﬁcient BALB/c mice have shown that
IL-4-mediated exacerbation of CL is dependent upon the
particular strain of Leishmania [13]. IL-10 and TGF-β have
been shown both in human and experimental models of
disease to suppress healing responses and prevent parasite
clearance by the host [12, 14–16].
The clear Th1/Th2 dichotomy observed in murine cuta-
neous leishmaniasis has not been demonstrated in humans,
as the factors governing the nature of the host immune
response and disease outcome during leishmaniasis are far
more complex in men than in mice [14]. It is clear however,
in both human and experimental models of disease, that
cytokines play a critical role in shaping the nature of the host
immune response in response to Leishmania infection.
Cytokines signal through a cascade of intracytoplasmic
proteins known as STATs (signal transducer and activator of
transcription)[17].Thesetranscriptionfactorsareindispens-
able for mediating biological activities of cytokines and for
induction of cytokine-responsive genes. STATs are activated
by tyrosine phosphorylation by cytokine receptor-associated
Jak kinases. Upon activation, the STATs are phosphorylated
and dimerize through their SH2 domain to form homo- or
heterodimers. These dimers translocate to the nucleus where
they bind to the promoter region of genes via speciﬁc DNA
binding domains and thus bring about the transcription of
their respective genes [17–20].
Here, we discuss the signature cytokines and complex
STAT-mediated signaling networks involved in regulating
the host response and determining disease outcome during
cutaneous and visceral leishmaniasis.
2. Interferon-γ (IFN-γ) andSTAT1
The development of cell-mediated immune responses capa-
ble of controlling Leishmania infection and resolving disease
is critically dependent upon signaling by interferon gamma
(IFN-γ), a type II interferon secreted primarily by activated
T cells and NK cells in response to IL-12 signaling [21].
The major biological function of IFN-γ is to activate
macrophages and enhance the microbicidal activity of these
cells to kill intracellular pathogens [22]. IFN-γ induces
iNOS (inducible nitric oxide synthase) expression and NO
production by phagocytes harboring intracellular parasites
and is required for activating macrophages to eliminate
parasites and resolve Leishmania infection [9, 10].
The biological eﬀects of IFN-γ are largely dependent
upon the activation of STAT1 transcription factors. Upon
IFN-γ/IFNγR ligation, STAT1 is phosphorylated and STAT1
homodimers associate and translocate into the nucleus to
initiate gene transcription [21]. IFN-γ-dependent immune
responses against microbial pathogens are severely impaired
in mice genetically deﬁcient in STAT1 [23]. In experimental
models of cutaneous L. major infection, STAT1−/− mice
developed extensive tissue destruction and severe inﬂamma-
tory inﬁltrates composed heavily of neutrophils and para-
sitized macrophages [24]. STAT1/IFN-γ signaling pathway
also induces the expression of Th1-associated transcription
factor, T-bet. Both STAT1 and T-bet are required to mount
an eﬃcient Th1 response and as such, are indispensable
for host defense against Leishmania infection in mice [19,
25]. In contrast, STAT1−/− mice are resistant to visceral
infection with L. donovani even in the absence of a strong
Th1 response and develop minimal liver pathology. Studies
in these mice have opened the possibility that resistance
in STAT1−/− mice is due to a defect in the traﬃcking
of monocytes and an inability of parasites to establish a
successful infection [19]. In fact, a recent study by our group
has shown that STAT1 in CD4+ T cells plays a critical role
in immunity to L. major by mediating recruitment of T cells
to the site of infection [26]. This is perhaps not surprising
since STAT1 is required for eﬃcient induction of C-X-C
chemokine receptor 3 (CXCR3) on CD4+ T cells [27]w h i c h
is critical for eﬃcient recruitment to the site of infection
[28]. Interestingly, STAT1 in T cells is not necessary for
Th1 development and IFN-γ production during L. major
infection [26, 29].
3. Interferon-α/β (IFN-α/β)andSTAT2
Type I interferons α and β (IFN-α/β) are proinﬂam-
matory cytokines that signal through the activation and
phosphorylation of STAT1 and STAT2. Studies using mice
deﬁcient of STAT1 and STAT2 have shown that both these
transcription factors are required for mediating most of
the proinﬂammatory eﬀects of these cytokines [30]. In
cutaneous infection with L. major,I N F - α/β have been shown
to act as early regulators of the innate response to infection
and are required for initiating the expression of nitric oxide
synthase type 2 (NOS2) and the production of NO [30].
The expression of NOS2 by macrophages has been shown
to play an important role in protection against intracellular
parasit ess uc hascrypt oc oc ci,Toxoplasma,mycobacteria,and
Leishmania. A study by Bogdan et al. found that type I
IFN-α/β are required for initial NOS2 expression [30]. Via
NOS2, IFNα/β play a critical role in the innate response
to CL infection by mediating events involved in parasite
containment, IFN-γ expression, and the activity of cytotoxic
NK cells [30].
Mice deﬁcient of STAT2 are known to demonstrate
an increased susceptibility to viral infections and impaired
responsiveness to type I interferons [31]. In CL caused
by L. amazonesis, infection with intracellular amastigotes
was found to reduce STAT2 phosphorylation and enhance
STAT2 degradation through the activity of parasite-derived
proteases in DC from infected C57BL/6 and BALB/c mice.
The role of STAT2 in VL is largely unknown [31].Journal of Biomedicine and Biotechnology 3
4.Interleukin-12(IL-12) andSTAT4
The proinﬂammatory cytokine, IL-12, is a heterodimer
composed of two subunits, p35 and p40 and is produced
primarily by macrophages and dendritic cells (DCs) in
response to microbial pathogens [32]. IL-12 functions as
the main physiological inducer of gamma interferon (IFN-
γ) by activated T cells and promotes Th1-type CD4+ T
cell diﬀerentiation, and therefore plays an important role in
inducing cell-mediated protection in response to Leishmania
infection [33].
The importance of IL-12 in immunity to CL has been
clearly demonstrated in experimental models of L. major
infection: animals genetically deﬁcient in the IL-12 gene or
genetically resistant mice treated with anti-IL-12 antibodies
fail to control parasite replication and are unable to resolve
infection, and treatment of genetically susceptible BALB/c
micewithrecombinantIL-12issuﬃcienttoconferresistance
in these animals [34]. Similarly, a comparison between
L. donovani-infected IL-12+/+ and IL-12−/− C57BL/6 mice
showed a higher parasitic burden in the livers of infected IL-
12−/− mice [35].
The speciﬁc cellular eﬀects of IL-12 are due to the
activation of Janus kinase (JAK)-STAT pathways, primarily
to the activation of the speciﬁc transcription factor, STAT4
[32]. STAT4 is one of seven members of the STAT family of
transcription factors and is the major STAT activated by IL-
12 [33]. In activated T cells and NK cells, STAT4 functions to
induce IFN-γ production in response to IL-12 signaling. IL-
12 signaling leads to activation of STAT4 by Jak kinase Jak2
and Tyk2. STAT4 dimers translocate into the nucleus and
bind DNA sequences at IFN-γ activation site (GAS) [17, 18].
IL-12-induced IFN-γ mediates most of the proinﬂammatory
activities of IL-12 and is critical for Th1 diﬀerentiation and
directing the cell-mediated immune response required for
protection against Leishmania infection.
STAT4-deﬁcient mice are viable but have impaired
Th1 diﬀerentiation, IFN-γ production, and cell-mediated
immunity, phenotypes shared by mice lacking IL-12 or IL-
12R subunits [33]. In experimental models of cutaneous
leishmaniasis, STAT4-dependent IL-12 signaling was found
to be crucial for the development of protective immunity as
evidenced by the increased susceptibility observed in STAT4-
deﬁcient mice to L. major [32], and STAT4/STAT6−/− mice
to L. mexicana [36].
5.IL-4,IL-13 andSTAT6
IL-4 and IL-13 are the signature cytokines associated
with Th2-type immune responses and are associated with
nonhealing forms of cutaneous disease in mice [9]. IL-4
stimulates the diﬀerentiation of na¨ ıve CD4+ T cells into
Th2 cells capable of producing Th2-associated cytokines
IL-5, IL-10 and IL-13, and promotes antibody production
and IgE class switching by B cells. IL-4 also functions as a
powerful inhibitor of IFN-γ-producing CD4+ T cells and
suppressor of protective Th1 immune responses [37]. IL-4,
along with related cytokine IL-13, trigger macrophages to
undergo alternative activation and is associated with parasite
survival and persistence of infection [9, 10, 24].
The IL-4R and IL-13R share a common γcr e c e p t o rc h a i n
involved in signal transduction. Both IL-4 and IL-13 are
the principal activators of transcription factor STAT6 which
mediates most biological activities of these cytokines [38].
STAT6−/− mice show impaired Th2 diﬀerentiation and lose
responsiveness to IL-4 and IL-13 while maintaining normal
responses to other cytokine signals [23].
The importance of IL-4, IL-13, and STAT6 in mediating
susceptibility during cutaneous infection was clearly demon-
strated in experimental models of L. mexicana infection
using genetically susceptible mice deﬁcient in the genes
for IL-4, IL-13, and STAT6. IL-4−/−,I L - 1 3 −/−,I L - 4 −/−/IL-
13−/−,a n dS T A T 6 −/− mice all mount a robust Th1 response
and eﬀectively control parasite growth and replication,
indicating that IL-4, IL-13, and STAT6 mediate susceptibility
by preventing the development of protective Th1 responses
[5, 39].
L. donovani-infected mice have been demonstrated to
p r o d u c eI L - 4i ns o m em o d e l sa n dn o ti no t h e r s[ 40, 41].
However, IL-4 does not seem to play a part in promoting
susceptibility to L. donovani as susceptible phenotypes have
beenshown evenin the absenceofIL-4[41].Inexperimental
models of visceral infection in mice, IL-4 has been found
to play no antagonistic role in eliminating infection [40].
SomestudieshaveactuallyshownthatIL-4−/− micearemore
susceptible to infection with L. donovani t h a nwi l dt yp em i c e
and suggest a protective role for IL-4 in VL [8, 39]. Since
IL-4 does not seem to exacerbate L. donovani infection, it
appears that Th2 responses are not important in suppressing
the protective Th1 immune response. Furthermore, the
assumption that treatment of VL should be enhanced in
absence of IL-4 was shown not to be true. In fact, L.
donovani-infectedIL-4−/− micewereseentobeassusceptible
to infection as wild type mice. Rather, resolution of infection
upon drug treatment was more eﬀective in wild type mice
as compared to IL4−/− mice [8]. The ﬁndings suggest a
role for IL-4 in enhancing the protective role of IFN-γ.
Experimental studies in BALB/c mice genetically deﬁcient in
IL-4 were found to respond poorly to chemotherapy with
sodium stibogluconate and these mice were also found to
producelittleIFN-γ.ArecentstudyhasshownthatIL-4plays
a critical role in vaccine induced protection against VL by
enhancing IFN-γ production by CD8+ T cells [42].
6.IL-10 andSTAT2
The anti-immune and anti-inﬂammatory cytokine, IL-10 is
produced by a variety of cells including T cells, monocytes,
macrophages, DCs, and B cells [15]. While many cells can
produce IL-10, the main biological functions of IL-10 appear
to be on macrophages and DCs. IL-10 functions to inhibit
the production of proinﬂammatory cytokines IL-1, IL-6,
IL-12, and tumor necrosis factor (TNF) by macrophages
and DCs [23] and thus prevents the expansion of Th1-type
cells required for protective immunity during Leishmania
infection [14–16].4 Journal of Biomedicine and Biotechnology
IL-10 also promotes activation, survival, and antibody
production by B cells and the development of humoral
immune responses which play a detrimental role in host
defense against Leishmania infection by facilitating parasite
entry into host cells [43]. In both human and experimental
models of CL, high levels of IL-10 production are strongly
associated with nonhealing forms of disease [9, 15].
IntheabsenceofIL-10(IL-10−/−),geneticallysusceptible
C57BL/6 mice mount an immune response capable of
controlling parasite replication and resolving cutaneous
infection with L. mexicana.I L - 1 0 −/− mice were found to
e x p r e s sh i g h e rl e v e l so fI F N - γ a n dp r o d u c e dm o r eN Ot h a n
C57BL/6 IL-10+/+ mice. IL-10 also mediates susceptibility
and promotes parasite persistence in cutaneous infections
with L. major,h o w e v e ri t sr o l ei nL. amazonensis and L.
pifanoi infection remains unclear [15].
Increased IL-10 production has been reported in patients
suﬀering from VL as well as mice infected with L. donovani
[44]. IL-10 levels decline upon resolution of VL following
chemotherapy indicating that IL-10 is a susceptibility factor
in VL [45, 46]. In fact, IL-10
−/− mice are highly resistant to
L. donovani [45, 47]. Furthermore, a correlation was found
between decreasing levels of IL-10 and resolution of VL in
these models. Since IL-10 can act as an inhibitor of IFN-γ
induced NO synthesis, it is likely that antagonistic eﬀect of
IL-10ismediatedbyitsabilitytosuppressproductionofNO,
which is critical for elimination of parasites [45].
Various STAT transcription factors appear to be involved
in IL-10 production by T cells, B cells, NK cells, monocytes,
and macrophages; however, STAT3 plays a conserved role in
IL-10 signaling in all cell types [48]. STAT3 is a common
transcription factor in signaling by a variety of cytokines,
including members of the IL-6 family of cytokines, granu-
locyte CSF, EGF, IFN-γ, and IL-2 [49].
STAT3-deﬁcient mice are not viable and experience early
fetal death. However, conditional cell-speciﬁc knockouts of
the STAT3 gene using the Cre-loxP system have demon-
strated an important role for STAT3 signaling in IL-6- and
IL-2-induced proliferation by T cells [23, 49]. In similar
studies, IL-10 was demonstrated to play an essential role
in the deactivation of macrophages and neutrophils. IL-
10-deﬁcient mice exhibited increased production of proin-
ﬂammatory cytokines such as TNFα,I L - 1 ,I F N - γ,a n dI L -
6 and a polarized immune response towards a Th1-type
response [23, 50]. The speciﬁc role of STAT3 signaling
in leishmaniasis has not been demonstrated and requires
further investigation.
7. Conclusion
The pathology and resolution of leishmaniasis is dependent
to a large extent on the infecting species, and the model used.
Cytokines do have a role in all cases either by initiating the
development of a Th1 response as in VL or development of
Th2 response in case of CL. The major cytokines in both
cases are IL-12, IFN-γ, IL-10, IL-4, the eﬀects of which are
mediated by speciﬁc STATs.
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